News from the fight to
#SaveIndependentPharmacy
New York Times The Middlemen series
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.
Legalized Racketeering? How PBMs Skirt the Law to Rake in Billions
Pharmacy Benefit Managers (PBMs) have been under scrutiny lately for their actions as middlemen in the flow of prescription drugs from manufacturers to patients. But perhaps their worst actions are buried within a maze of consolidation and paperwork. Big Insurance has consolidated the entire pharmaceutical benefit, claim, and dispensing sector to squeeze as much money out of patients as possible.
Senator Wiener Responds to Governor’s Veto of Pharmacy Benefit Manager Bill
California Gov. Gavin Newsom vetoed legislation to rein in anticompetitive practices pharmacy benefit managers (PBMs) are using to drive up prescription drug prices and forcing independent pharmacies out of business. As a result, California remains one of the only states to leave the industry, which controls virtually all prescription drugs on the market, essentially unregulated. As a result, Californians will continue to pay more for health care and will continue to have limited access to their neighborhood pharmacies.
FTC head Lina Khan fighting Big Tech, Big Pharma and Big Groceries as trustbuster
FTC Chair Lena Khan was featured on a segment of 60 Minutes this past Sunday. The youngest-ever chair of the Federal Trade Commission sat down with Lesley Stahl to discuss how corporate consolidation and anti-competitive business practices are driving up prices throughout the U.S. economy.
Bruised by Government Report, Cigna's Pharmacy Business Sues the Federal Trade Commission
Whistleblower, former Cigna VP, and reformed insurance propagandist Wendell Potter takes you behind the scenes to provide a glimpse into the reasoning behind the lawsuit his former company filed this week against the Federal Trade Commission (FTC).
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
Caremark, Express Scripts, Optum, and their affiliates created a broken rebate system that inflated insulin drug prices, boosting PBM profits at the expense of vulnerable patients, the FTC alleges.
Press Conference on PBM Abuse & H.R.9096 The Pharmacists Fight Back Act
Representatives Jake Auchincloss (D - MA) and Diana Harshbarger (R - TN) hold a press conference on PBM abuses, the destruction it causes to patients and pharmacies, and how The Pharmacists Fight Back Act H.R.9096 will stop it!
Rally outside Optum HQ brings debate over pharmacy benefits managers to Twin Cities
Patients, providers, and legislators gathered to allege biggest players are ballooning drug costs while running independent pharmacies out of business; Optum denied claims.
Senator Wiener’s Landmark Prescription Drug Prices Bill Heads to the Governor
The landmark piece of legislation would have enacted the nation’s strongest regulations to rein in exploitative behavior by pharmacy benefit managers, also known as PBM abuse. The bill passed with bipartisan support in the state legislature only to be vetoed by California Governor Gavin Newsom.
Podcast: PBM Problems (Part 3): Monopoly Power in Prescription Drug Markets with Luke Slindee, PharmD
We all know the cost of prescription drugs in the U.S. is a problem. How did we get here and what can we do about it?
From the podcast MTVA Unscripted: Empowering the Move to Value Based Healthcare
Minnesota branch of the Harris-Walz campaign holds panel to celebrate the anniversary of the Inflation Reduction Act
Our owner and pharmacist John Hoeschen was a featured panelist at a prescription drug cost roundtable hosted by the Harris-Walz campaign in Rochester, MN.
Why Walgreens And CVS Are Shutting Down Thousands Of Stores
In its fiscal third-quarter report, Walgreens announced its plans to close a ‘significant’ amount of stores, acknowledging only 75% of its 8,600 stores were profitable. While no specific stores were tapped for closure yet, more than 2,000 locations could face the chopping block by 2027. This just the latest sign of trouble for the struggling retail pharmacy sector as CVS and Rite Aid both announced large closures in the past year. Watch the video to learn why U.S. pharmacy chains are fighting for survival.
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
Pharmacy Benefit Managers (PBMs) are driving up drug costs for millions of people, employers and the government.
The second in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs.
The Hidden Cost of Underwater Reimbursements
Are below cost reimbursement practices by Pharmacy Benefit Managers creating opportunity for criminals to enter the legitimate supply chain?
The biggest Pharmacy Benefit Managers (PBMs) are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.
The third in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs .